ClinVar Miner

Submissions for variant NM_138694.4(PKHD1):c.7675G>C (p.Val2559Leu)

gnomAD frequency: 0.00070  dbSNP: rs150046042
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000178676 SCV000230801 uncertain significance not provided 2018-03-15 criteria provided, single submitter clinical testing
Blueprint Genetics RCV000178676 SCV000927493 uncertain significance not provided 2017-12-12 criteria provided, single submitter clinical testing
Invitae RCV000806672 SCV000946685 likely benign Autosomal recessive polycystic kidney disease 2024-01-27 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000806672 SCV001320060 uncertain significance Autosomal recessive polycystic kidney disease 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001358740 SCV001554588 uncertain significance not specified 2024-01-26 criteria provided, single submitter clinical testing Variant summary: PKHD1 c.7675G>C (p.Val2559Leu) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0012 in 1613106 control chromosomes in the gnomAD database, including 2 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in PKHD1 causing Polycystic Kidney And Hepatic Disease (0.0012 vs 0.0071), allowing no conclusion about variant significance. c.7675G>C has been reported in the literature in individuals affected with Polycystic Kidney And Hepatic Disease without strong evidence for causality (e.g. Sharp_2005, Tavira_2015). These report(s) do not provide unequivocal conclusions about association of the variant with Polycystic Kidney And Hepatic Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 15805161, 25701400). ClinVar contains an entry for this variant (Variation ID: 197602). Based on the evidence outlined above, the variant was classified as uncertain significance.
Ambry Genetics RCV003352795 SCV004054814 uncertain significance Inborn genetic diseases 2023-08-02 criteria provided, single submitter clinical testing The c.7675G>C (p.V2559L) alteration is located in exon 48 (coding exon 47) of the PKHD1 gene. This alteration results from a G to C substitution at nucleotide position 7675, causing the valine (V) at amino acid position 2559 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
PreventionGenetics, part of Exact Sciences RCV003977466 SCV004795668 likely benign PKHD1-related condition 2024-01-05 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Natera, Inc. RCV000806672 SCV001455249 uncertain significance Autosomal recessive polycystic kidney disease 2018-03-26 no assertion criteria provided clinical testing
Laboratory of Gastroenterology and Hepatology, Radboud University Medical Center RCV001844817 SCV001877014 likely benign Autosomal dominant polycystic liver disease 2021-09-01 no assertion criteria provided research
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000178676 SCV001930057 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000178676 SCV001964007 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.